Xingyao Bu

1.9k total citations
49 papers, 1.3k citations indexed

About

Xingyao Bu is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Xingyao Bu has authored 49 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 21 papers in Cancer Research and 15 papers in Genetics. Recurrent topics in Xingyao Bu's work include Glioma Diagnosis and Treatment (13 papers), Cancer Genomics and Diagnostics (6 papers) and Protease and Inhibitor Mechanisms (5 papers). Xingyao Bu is often cited by papers focused on Glioma Diagnosis and Treatment (13 papers), Cancer Genomics and Diagnostics (6 papers) and Protease and Inhibitor Mechanisms (5 papers). Xingyao Bu collaborates with scholars based in China, United States and Netherlands. Xingyao Bu's co-authors include Jerome I. Rotter, Aldons J. Lusis, M van Linde-Sibenius Trip, Geesje M. Dallinga‐Thie, T W de Bruin, Zhaoyue Yan, Ignacio Gonzales-Gomez, Walter E. Laug, Vazgen Khankaldyyan and Shinya Yamada and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Xingyao Bu

47 papers receiving 1.3k citations

Peers

Xingyao Bu
Conrad P. Hodgkinson United States
Michael J. Tolentino United States
Bendi Gong United States
Courtney T. Griffin United States
John Doukas United States
Xingyao Bu
Citations per year, relative to Xingyao Bu Xingyao Bu (= 1×) peers Joo‐ri Kim‐Kaneyama

Countries citing papers authored by Xingyao Bu

Since Specialization
Citations

This map shows the geographic impact of Xingyao Bu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingyao Bu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingyao Bu more than expected).

Fields of papers citing papers by Xingyao Bu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingyao Bu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingyao Bu. The network helps show where Xingyao Bu may publish in the future.

Co-authorship network of co-authors of Xingyao Bu

This figure shows the co-authorship network connecting the top 25 collaborators of Xingyao Bu. A scholar is included among the top collaborators of Xingyao Bu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingyao Bu. Xingyao Bu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Guanzheng, Zhiyue Zhang, Meiyun Wang, et al.. (2023). Genomic alterations of oligodendrogliomas at distant recurrence. Cancer Medicine. 12(16). 17171–17183. 8 indexed citations
2.
Liu, Guanzheng, Zhiyue Zhang, Kaiyuan Deng, et al.. (2023). Molecular and clonal evolution in vivo reveal a common pathway of distant relapse gliomas. iScience. 26(9). 107528–107528. 7 indexed citations
3.
Liu, Zhendong, Xingbo Cheng, Runze Liu, et al.. (2022). DRAXIN as a Novel Diagnostic Marker to Predict the Poor Prognosis of Glioma Patients. Journal of Molecular Neuroscience. 72(10). 2136–2149. 1 indexed citations
4.
Andrade-Barazarte, Hugo, Ajmal Zemmar, Sijia Li, et al.. (2021). Characterizing the Genomic Landscape of Brain Glioma With Circulating Tumor DNA From Tumor In Situ Fluid. Frontiers in Oncology. 11. 584988–584988. 14 indexed citations
5.
Ding, Chenyu, Xuehan Yi, Xiangrong Chen, et al.. (2021). Warburg effect-promoted exosomal circ_0072083 releasing up-regulates NANGO expression through multiple pathways and enhances temozolomide resistance in glioma. Journal of Experimental & Clinical Cancer Research. 40(1). 164–164. 112 indexed citations
6.
Chen, Zhongcan, Yong Sun, Xingyao Bu, et al.. (2021). Constrained-Spherical Deconvolution Tractography in the Evaluation of the Corticospinal Tract in Glioma Surgery. Frontiers in Surgery. 8. 646465–646465. 7 indexed citations
7.
Ding, Chenyu, Xuehan Yi, Zhenhua Huang, et al.. (2020). Long Non-Coding RNA MEG3 Modifies Cell-Cycle, Migration, Invasion, and Proliferation Through AKAP12 by Sponging miR-29c in Meningioma Cells. Frontiers in Oncology. 10. 537763–537763. 20 indexed citations
9.
Ma, Chunxiao, Wei Zhou, Zhaoyue Yan, Mingqi Qu, & Xingyao Bu. (2016). β-Elemene treatment of glioblastoma: a single-center retrospective study. OncoTargets and Therapy. Volume 9. 7521–7526. 18 indexed citations
10.
Yuan, Qiang, Xingyao Bu, Zhaoyue Yan, et al.. (2016). Combination of endogenous neural stem cell mobilization and lithium chloride treatment for hydrocephalus following intraventricular hemorrhage. Experimental and Therapeutic Medicine. 12(5). 3275–3281. 4 indexed citations
11.
Ma, Chunxiao, Wei Zhou, Zhaoyue Yan, Mingqi Qu, & Xingyao Bu. (2015). Toll-like receptor 4 (TLR4) is correlated with delayed cerebral ischemia (DCI) and poor prognosis in aneurysmal subarachnoid hemorrhage. Journal of the Neurological Sciences. 359(1-2). 67–71. 24 indexed citations
12.
Ma, Chunxiao, et al.. (2012). Efficacy and cost analysis of microsurgical clipping and vascular embolization in treatment of patients with cerebral aneurysms. Chinese Journal of Neuromedicine. 11(7). 709–712. 2 indexed citations
13.
Yamada, Shinya, Xingyao Bu, Vazgen Khankaldyyan, et al.. (2006). EFFECT OF THE ANGIOGENESIS INHIBITOR CILENGITIDE (EMD 121974) ON GLIOBLASTOMA GROWTH IN NUDE MICE. Neurosurgery. 59(6). 1304–1312. 107 indexed citations
14.
15.
Bu, Xingyao, Vazgen Khankaldyyan, Ignacio Gonzales-Gomez, et al.. (2004). Species-specific urokinase receptor ligands reduce glioma growth and increase survival primarily by an antiangiogenesis mechanism. Laboratory Investigation. 84(6). 667–678. 26 indexed citations
16.
Zhang, Xiang, Zhou Fei, Xingyao Bu, et al.. (2000). Expression and significance of urokinase type plasminogen activator gene in human brain gliomas. Journal of Surgical Oncology. 74(2). 90–94. 23 indexed citations
17.
Florentine, Barbara D., et al.. (2000). Fine-needle aspiration of a metaplastic breast carcinoma with extensive melanocytic differentiation: A case report. Diagnostic Cytopathology. 23(1). 46–50. 17 indexed citations
18.
Dallinga‐Thie, Geesje M., M van Linde-Sibenius Trip, Jerome I. Rotter, et al.. (1997). Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes.. Journal of Clinical Investigation. 99(5). 953–961. 99 indexed citations
19.
Bu, Xingyao, Craig H. Warden, Danny D. Shen, et al.. (1996). Quantitative trait locus mapping of human blood pressure to a genetic region at or near the lipoprotein lipase gene locus on chromosome 8p22.. Journal of Clinical Investigation. 97(9). 2111–2118. 95 indexed citations
20.
Bu, Xingyao & Jerome I. Rotter. (1993). Wolfram syndrome: a mitochondrial-mediated disorder?. The Lancet. 342(8871). 598–600. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026